Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Like it or not, this is off to $60+
Should be $40 very soon imo.
leukemia news worth $90
Shorts wait until Monday so they dont run into a weekend buyout ! Rising into end of week and month ! See 30s soon imo.
Market cap of AVXL is only 250 million, KITE just rose to 3 Billion, GILD and BIIB 94 BILLION. Imo this still is cheap at $100.
KITE move is nothing compared to what AVXL can do in Alzheimers, Parkinsons, Epilepsy, MS and other CNS diseases including Rhetts.
Report seems conservative in $30s.
2 Top picks: KITE in lymphoma and AVXL in Alzheimers !
Chart breaks upward with yesterdays close and presentation now weeks away.
OWCP vs. SGMD, which one is being called the Fedex of Cannabis and only has 40 million shares outstanding?
SGMD: The Fedex of Cannabis !
Easy triple from here.
Each day gets us closer to big news1
1/4 share of BIIB could possibly get it done today. 1/2 share of BIIB would have to be paid later in the year imo.
A small billion to a billion and a half buy out takes us to $30. BP has lost 10s of billions in market cap in failed AD trials. This would be a drop in the bucket and can return them 100x their money imo.
Buying today. Options expire. Phase2 and phase 2/3 trials begin soon and 15 month Alzheimer results presented next month. Patients will be knocking down the door for this drug as the caregivers and family members extended a 6 month trial from 6 months to one year now to 2 years because its working, due your DD and watch the webcast.
The Low Float Stocks to Watch are: HMNY ( 1 million float), QBAK (890 thousand float) and SPU ( 1.7 million float).
Low Float stocks to watch: HMNY (1 million float), SPU (1.7 million float) and QBAK ( only 890 thousand float).
URRE is a Lithium stock now, look at the prices of ALB and FMC. Love their lithium properties in a great area as well. The low float runners to watch are: QBAK (890 thousand shares in float), SPU (1.7 m float) and HMNY (1 m float).
UP TREND, glad you grabbed SGNL and we both did well in ETRM. Watch QBAK now and AVXL for 2017. Let me know your short term ideas.
Watch QBAK, only 890 thousand in float. Hope you did well in ETRM and DNNF as well.
UP TREND, You are welcome for SGNL, I also mentioned ETRM and DNNF. I saw you bought from your post 3377 in reply to my post 3325, Watch QBAK ! And for 2017 my top pick is AVXL.
Watch SGNL.
SGNL, only 400 thousand float !
Watch DFFN !
ARIA bought for 5.2 BILLION. That is about $80 for AVXL, right?
ARIA bought for 5.2 BILLION, can you say $500 for ETRM?
Soon to catch GWPH. Could see $30 this month.
Jump up $1 to $2 daily..Watch the hedge fund volume !
Charts show a retest of $14 and a break through to $22
Market 2-73 as a Vitamin and you would see Billions in sales Worldwide. No approval needed, no prescription needed, little capital needed. It would be a $30+ stock overnight.
NASH agreement values CNAT at $15+ currently IMO.
This news brings $20+ as we approach mosquito season in the Spring.
Make A2-73 a Billion dollar Vitamin. No FDA waiting and would be sold Worldwide ! Everyone would buy it for family members with no doctor visits either !!
Should be valued at $15+ currently with NASH development.
Huge News. Longer term could see $15+ as it was before without this news.
It does seem to be trending favorable as environment is leaning in favor of GSAT and its future in iot. The sector needs GSAT and management is proactive. $20 possible?
Was $110 before drug approval delay last November, now that drug is FDA approved !
Is it that the new CEO and Missling are friends?
BIIB New CEO looks and speaks like Dr. Missling, I bet they are great friends.